Towa Pharmaceutical Co., Ltd. (FRA:6QC)

Towa Pharmaceutical Statistics

Total Valuation

FRA:6QC has a market cap or net worth of EUR 875.41 million. The enterprise value is 1.91 billion.

Market Cap	875.41M
Enterprise Value	1.91B

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	49.23M
Shares Outstanding	n/a
Shares Change (YoY)	+0.01%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	3.00%
Owned by Institutions (%)	17.67%
Float	23.01M

Valuation Ratios

The trailing PE ratio is 7.36.

PE Ratio	7.36
Forward PE	n/a
PS Ratio	0.57
PB Ratio	0.85
P/TBV Ratio	1.11
P/FCF Ratio	n/a
P/OCF Ratio	5.27
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.73, with an EV/FCF ratio of -292.91.

EV / Earnings	16.06
EV / Sales	1.29
EV / EBITDA	7.73
EV / EBIT	14.88
EV / FCF	-292.91

Financial Position

The company has a current ratio of 2.80, with a Debt / Equity ratio of 1.31.

Current Ratio	2.80
Quick Ratio	1.28
Debt / Equity	1.31
Debt / EBITDA	5.30
Debt / FCF	-208.71
Interest Coverage	11.59

Financial Efficiency

Return on equity (ROE) is 12.18% and return on invested capital (ROIC) is 3.64%.

Return on Equity (ROE)	12.18%
Return on Assets (ROA)	3.14%
Return on Invested Capital (ROIC)	3.64%
Return on Capital Employed (ROCE)	5.95%
Revenue Per Employee	320,757
Profits Per Employee	24,833
Employee Count	4,788
Asset Turnover	0.58
Inventory Turnover	1.51

Taxes

In the past 12 months, FRA:6QC has paid 42.27 million in taxes.

Income Tax	42.27M
Effective Tax Rate	26.23%

Stock Price Statistics

The stock price has increased by +1.16% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.16%
50-Day Moving Average	16.10
200-Day Moving Average	16.81
Relative Strength Index (RSI)	76.02
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:6QC had revenue of EUR 1.54 billion and earned 118.90 million in profits. Earnings per share was 2.42.

Revenue	1.54B
Gross Profit	558.76M
Operating Income	133.46M
Pretax Income	161.17M
Net Income	118.90M
EBITDA	256.73M
EBIT	133.46M
Earnings Per Share (EPS)	2.42

Balance Sheet

The company has 285.52 million in cash and 1.36 billion in debt, giving a net cash position of -1.08 billion.

Cash & Cash Equivalents	285.52M
Total Debt	1.36B
Net Cash	-1.08B
Net Cash Per Share	n/a
Equity (Book Value)	1.04B
Book Value Per Share	21.04
Working Capital	948.55M

Cash Flow

In the last 12 months, operating cash flow was 166.09 million and capital expenditures -172.61 million, giving a free cash flow of -6.52 million.

Operating Cash Flow	166.09M
Capital Expenditures	-172.61M
Free Cash Flow	-6.52M
FCF Per Share	n/a

Margins

Gross margin is 36.38%, with operating and profit margins of 8.69% and 7.74%.

Gross Margin	36.38%
Operating Margin	8.69%
Pretax Margin	10.49%
Profit Margin	7.74%
EBITDA Margin	16.72%
EBIT Margin	8.69%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.47, which amounts to a dividend yield of 2.71%.

Dividend Per Share	0.47
Dividend Yield	2.71%
Dividend Growth (YoY)	28.70%
Years of Dividend Growth	n/a
Payout Ratio	16.94%
Buyback Yield	-0.01%
Shareholder Yield	2.70%
Earnings Yield	13.58%
FCF Yield	-0.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:6QC has an Altman Z-Score of 1.87 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.87
Piotroski F-Score	6